{"name":"atai Therapeutics, Inc.","slug":"atai-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"DMX-1002","genericName":"DMX-1002","slug":"dmx-1002","indication":"Other","status":"phase_1"},{"name":"VLS-01-203 BU","genericName":"VLS-01-203 BU","slug":"vls-01-203-bu","indication":"Other","status":"phase_2"},{"name":"EMP-01","genericName":"EMP-01","slug":"emp-01","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"DMX-1002","genericName":"DMX-1002","slug":"dmx-1002","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"VLS-01-203 BU","genericName":"VLS-01-203 BU","slug":"vls-01-203-bu","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EMP-01","genericName":"EMP-01","slug":"emp-01","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQYmw5SkoxVEYwZldReFJlS0IyLUwxa2hQbUNUa2FMdGNTeTVpTHZmSXNRM3UxeWVaMmRYUU1KNldFU1lGNzBZczdKay1NYzFfb3JFNmtGVmxUT0lSQVh5TjU5V2ducnJ2VzVnb1BiT0lIOW5zbXBBLVk4ZEllRGNwOS1sYVhBRFF2US03WVdpX09ia19iRUlteUg2V2U1NGhHWU1rUllmNFJYYmJleDlMd09PdzBTV1VvSXRDSWdHZmVUQVNBQVJNcENGVWc4NGd2OU5hbTlKd1NWbk1uZmlrVXYwYWRzWXp3cy1HU1lkVW1VWDg2Y1BrdnhibG1ZMnFPYV93bk9WVmpQcFlqME52OHpPRUxoR1RFVlBhMktMazVJU29ZMmdEcTBoMl9FZGhvTm5makctTHNSRTFwSUpr?oc=5","date":"2026-04-03","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and e","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPanFpYWk2V3pCSmVLVUI2ajE2NGVvNXMwVXdyVzE2V2pUcnhNUS1QVGdqWnU3UmlvUF9OcV85T2IyTE1ab0lZejl3b2JMb19HRWZMRHdvdGRWcGRGZHJUZVhsT0w1Mk16SjJWY3J1SW5OSG1URU9sbDZzd1ZqU1lBeHVtUXdrLU9vV0xLZ3czV3hJcHM4QmFERDdRVlp4aFhJSkJNQmRPRjhoc2YzMkFn?oc=5","date":"2026-03-31","type":"pipeline","source":"statnews.com","summary":"Over-the-top psychedelic promos could undermine the field’s drug development efforts - statnews.com","headline":"Over-the-top psychedelic promos could undermine the field’s drug development efforts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPLS15aGhrVms3Vk51SjlIMGd3SDgwTkhLdFJYT1E3RHFDaUR1Q08yV1psRC1wc1hJMU5fY2l1Z1pvaXhLLTZ4YjZ0OFFTQUtqaW1oMnB6blFuRVJYU1luRFVVaWFsMV9GNGNabGMwa2o1U0NzRGtOUmJKdXFEcnBZX1FTRk1HSXhkNUhWNjJTS1Y5cGhOODRJb1JBOUJBSUg2ZmdLclMzZU5GTmdPUGV5RXdBQllfSWFPeUY5dnlnVFBVRlREN2pLZlZEWQ?oc=5","date":"2026-03-09","type":"regulatory","source":"PR Newswire","summary":"CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions - PR Newswire","headline":"CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNMTc2TU15OHVOTXRQN1p2Yl8zXzV5RVhQcjBhY3JqcEJSRHhISlBzQlRxWnJ6T1FPZkxoTTVtV09aV1JXZVpSNTJZNFg3N3JtSXFIYWRHS1pNUzN1TnhnUXJtTXhpbDhYS3FMZ3FJMldlQTZEWTdpYkd1aDZzQ1MwbTRmckdjZ3VaMU94a2tXem5lZ0RxbHVEMTN0SjhzeFk4Zm5CQXdrZVVjY2psNFBVdkdHNHFrZHJEd1gwMWpUelRNRUd2T3ZTTERXbk1FNGYxZ1hFQ210c1NIZ2wwX2RmTlhTcGFfYXFSRkJrdmNyeFU4cEVDbGhSdGVfYlp6QQ?oc=5","date":"2026-03-09","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Conflicted on These Healthcare Names: Biohaven Ltd. (BHVN) and Atai Beckley N.V. (ATAI) - The Globe and Mail","headline":"Analysts Conflicted on These Healthcare Names: Biohaven Ltd. (BHVN) and Atai Beckley N.V. (ATAI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNVXZQWUVNNkl0X2g5eUR1a050UllScEFRQWE4Rk9pRWtJMnRucy1NQWhSZWd1ZmRDOENkZ2t4T21iTmkyaFMwZjZ4SWNXV1FibEYzbzRsbHozYmxnTzNnTzBWZ243Zkc0SVhUOUVJaU50OUo1cHlwN09NLVYxZ0VnWm9aXzloOE9iVkxmX28zbkdJWUlxZi1zR0gzckgxZXRNRnhNa2hQcU1jXzd0LVlRWkwzMHYwUGhJ?oc=5","date":"2026-03-05","type":"trial","source":"Benzinga","summary":"Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints - Helus Pharma (NASDAQ:HELP) - Benzinga","headline":"Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints - Helus Pharma (NASDAQ:HELP)","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOQi02bFd5Q1lxVkVfQkFpbWJZamFaOFo3YVNKT09va3RQSEloa2ROSDg4eEVzOTNkcFltQ1piaW9UdFh4ZFFBYzlBOF9oY3N2Rld3ZG1QREF2TkJBeEZkdE12Ml9fTXUtRFR5SmhyaVdGYmNWYVBOYm1ySGZvbWlFQUhKclh2aUhkVzRIUkFjZGxMeWdFZG1fQzBCMXVwaDRlM1UyNGZVTjlYYlBHaUgyTktCWVE1S1ZXeDZyZGZlczh3VFBJNDlpenF5NHNKdw?oc=5","date":"2026-02-27","type":"trial","source":"newswire.ca","summary":"Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments - newswire.ca","headline":"Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNRXFQSzVHZ0tjdGRNNXExQjdVRWJIOWswNUNPZWFvMHM3X3pSX01PM0VEVENBSkVSOC10aTlNc29oejZqcGZkcE1QbWtWeXZxYk1DZmVCSXRya1pjRnBMbVlvNDJobzFzVTdJMDV3Wm5kMFFFakRUZm9UQnAtcERVWWlmOF82RE11T2JQYWhzV1E1YkE?oc=5","date":"2026-02-05","type":"deal","source":"The Motley Fool","summary":"5 Psychedelic Stocks to Buy Now - The Motley Fool","headline":"5 Psychedelic Stocks to Buy Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQczNDQXFORU5ERlV2Y25XV2lJZFpnMVFlUTZjTjZ2UGlUQlV2SmdiZFFEaGxodERuaUdPRjlzeUhERE5Ra1RUejJPRlZEWkw5aVJOT2NmTXRYOE8tQUp5Mm43bUFFYjZ4QVo0VGRpTF9XRW0yeVIzeEJiMnFqbU1xdmJWR2UtTlIwUlHSAZIBQVVfeXFMUGRpOXphM2dMcVRoejhVUU93cjF1cmVuYTN0c0VDR1NUSExtV3NhSV9GNG9MekNFZDI5Qm5ua3Z1cmtUX2VXZ21hUXJlMkU1UFN2bzVIdFRxQTkyNU1mQTVGVk5mUkh0TVhhcW9Kd0JSRGZOXzh3RHlrMldHZzlRMHIyN3YybW9xd29ueE5qclNDcWc?oc=5","date":"2025-11-23","type":"pipeline","source":"Insider Monkey","summary":"9 Oversold Biotech Stocks to Invest In - Insider Monkey","headline":"9 Oversold Biotech Stocks to Invest In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNTzRqMkZJVUxwdklmSDR0aHAxWTFLQ0l0bFlzTFZOdTZlTFd1NEdINnhMLTJEeFVlNml5Q1htSzRsbkFZdzVMSndKMzF0VkdkSDdtR3JQSzF5OW5EQW0xbjdITlQ0bGpEWWQ3MlppV0RuY1lGSURZSzJoajNHYnFJWXNSSQ?oc=5","date":"2025-11-05","type":"deal","source":"pharmaphorum","summary":"Psychedelic merger to create AtaiBeckley completes - pharmaphorum","headline":"Psychedelic merger to create AtaiBeckley completes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1Vc3ItYVhTdXZ3V0JoU3FDQU5hX1ZpN2Y4VGtoLWkzSm9EM1BZcHBCa19kM2xHV1lJSFM0cExBeE5GOUdjTU04dTVpRV9ZXzlTek0tS0tSc1hPMlRRUjN5QmZIandNeEVKMGo3dA?oc=5","date":"2025-08-12","type":"pipeline","source":"Labiotech.eu","summary":"Six psychedelic drug companies aiming to revolutionize mental health treatment - Labiotech.eu","headline":"Six psychedelic drug companies aiming to revolutionize mental health treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQVjRxNUFHN3JuNTR6T1lyQm8wZUtxQUJQZDVVR3p6ZjhCaW1mUWJ5SktQOG9kTGxNRHlTb3UyeWpIRTZZZkk1VUYxQVU3cFJCMU9GUUUyb1pUZVZXdDhLbkwxNkxzeDlHQmloTTVvWVJYODdhbWFic0hIWmJmSTE2Qlp3?oc=5","date":"2025-07-06","type":"pipeline","source":"WSJ","summary":"The MAHA Movement Loves Psychedelics. Should Wall Street? - WSJ","headline":"The MAHA Movement Loves Psychedelics. Should Wall Street?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPc2xYeVo0b0VSa0Y5dU1aUlJjdG1NdC1ONEZ2S3k3TE9JLVNxdFFQT1FmZ3dkY09xck1NejV0N3VzYU5OM29UYVJUekhXSHVzUWZHbUdaVjdrQ2M0QWlxNWV3QWtvQmNOT1YzV2d0dDVxZkFpanNEYTEwZG9ldk5UYS0zbENrVFBHMFctLVFxMDZtVGxjVTVUQmZTR3E?oc=5","date":"2025-07-01","type":"trial","source":"BioPharma Dive","summary":"Atai and Beckley, set to merge, reveal study success for psychedelic drug - BioPharma Dive","headline":"Atai and Beckley, set to merge, reveal study success for psychedelic drug","sentiment":"positive"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":1,"phase_2":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}